(Q38004475)

26 August 2017

1 reference

title

Serotonin in human eating disorders (English)

1 reference

26 August 2017

0 references

1 reference

Jimerson DC

1

1 reference

26 August 2017

Lesem MD

series ordinal

2

1 reference

26 August 2017

Hegg AP

series ordinal

3

1 reference

26 August 2017

Brewerton TD

series ordinal

4

1 reference

26 August 2017

language of work or name

English

0 references

publication date

1 January 1990

1 reference

Annals of the New York Academy of Sciences

26 August 2017

published in

1 reference

26 August 2017

volume

600

1 reference

26 August 2017

page(s)

532-544

1 reference

Laboratory studies of eating behavior in women with bulimia

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Tryptophan depletion causes a rapid lowering of mood in normal males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Hormonal probes of central serotonergic activity: do they really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Bulimia. Its incidence and clinical importance in patients with anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

The validity of the distinction between bulimia with and without anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers. Important implications for neuroendocrine investigations in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Dieting and weight loss in volunteers increases the number of alpha 2-adrenoceptors and 5-HT receptors on blood platelets without effect on [3H]imipramine binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Effects of carbohydrate and protein meals on plasma large neutral amino acids, glucose, and insulin plasma levels of anorectic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Bingeing behavior and plasma amino acids: a possible involvement of brain serotonin in bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Phenelzine vs placebo in 50 patients with bulimia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Antidepressants and serotonergic neurotransmission: an integrative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Letter: Plasma-tryptophan in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

High affinity [3H]imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Differences in brain serotonergic metabolism between nonbulimic and bulimic patients with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

Involvement of serotonin system in bulimia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1990.TB16908.X

10.1111/J.1749-6632.1990.TB16908.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference